| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B05B5-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61J1-035 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B65B1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B65B11-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-54386
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7007
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-521
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61J3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B65B1-30 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B05B5-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61J1-03 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B65B1-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B65B1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B65B11-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61J3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-543
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70 |
| filingDate |
2001-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2002-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20020086689-A |
| titleOfInvention |
Biomedical assay device |
| abstract |
The present invention relates to an integrated structural unit comprising a diagnostic form comprising one or more active ingredients advantageously in an amount that does not change by more than about 5% from a predetermined target amount. In one embodiment, the unit form comprises a substrate, an attachment located on the substrate and a spreading layer that holds and spreads a liquid sample present on and assayed on the attachment. Attachments include powders comprising the active ingredient (s). Diagnostic forms are made through a dry powder attachment device that electrostatically attaches the powder onto a substrate using an electrostatic chuck and a charged powder delivery device. |
| priorityDate |
2000-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |